Hepatitis A Antibody, IgM CPT: 86709
Antibody to Hepatitis A Virus, IgM
This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin (also termed as vitamin B7 or B8, vitamin H, or coenzyme R). It is recommended to ask all patients who may be indicated for this test about biotin supplementation. Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.
Expected Turnaround Time
Within 1-2 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Serum or plasma
0.4 mL (Note: This volume does not allow for repeat testing.)
Red-top tube, gel-barrier tube, or lavender-top (EDTA) tube.
If a red-top tube is used, transfer separated serum to a plastic transport tube. Avoid hemolysis.
To help diagnose the cause of acute hepatitis; as part of a viral hepatitis panel to identify the type of hepatitis virus causing an infection; sometimes to evaluate the need for the hepatitis A vaccine.
When you have symptoms of an acute hepatitis infection, such as jaundice, or when you may have been exposed to hepatitis A virus (HAV).
A blood sample drawn from a vein in your arm.